Boeing will take a nearly $5 billion charge in the second quarter to compensate 737 Max customers as the planes remain grounded.Airlinesread more
Earlier, Williams delivered a speech at the annual meeting of the Central Bank Research Association in which he said, "It's better to take preventative measures than to wait...The Fedread more
Microsoft beat on top and bottom lines, and guidance was just ahead of expectations, but the company's Azure growth is slowing down.Technologyread more
"We've seen Netflix stumble before, especially maybe after a price hike, but not quite like this," Jim Cramer says.Mad Money with Jim Cramerread more
Trump said the USS Boxer destroyed Iran's drone in the Strait of Hormuz on Thursday in a "defensive action."Politicsread more
They also voted to absolve themselves, their party and the voters who elected them – like the ones Trump inspired to chant "send her back" at a rally Wednesday in North...Politicsread more
See which stocks are posting big moves after the bell on July 18.Market Insiderread more
House Democrats contend the $15 per hour minimum wage bill will lift workers who have not seen the benefits of a strong economy.Politicsread more
The Philadelphia Fed saw its primary gauge measuring the sector jump from 0.3 in June to 21.8, far better than Wall Street estimates of 5 and the highest in a year.Economyread more
"It's better to take preventative measures than to wait for disaster to unfold," Williams told the annual meeting of the Central Bank Research Association.The Fedread more
CrowdStrike reports first earnings report since IPO.Technologyread more
Former FDA Commissioner Scott Gotlieb told CNBC on Tuesday that "Medicare for All " — favored by many of the candidates seeking the 2020 Democratic presidential nomination — would eventually lead to a decline in health-care services in America.
"I don't think it is that feasible, quite frankly," said Gottlieb, who stepped down in April as the leader of the Food and Drug Administration under President Donald Trump. Medicare for All "would crowd out competition in private insurance and crowd out the kind of competition that puts downward pressure" on prices of drugs and medical services, Gottlieb said.
Trump, who appointed Gottlieb, has also criticized a Medicare for All approach. The president, a proponent of decreasing costs in health care, has tried to repeal and replace Obamacare.
In a "Squawk Box " interview, Gottlieb said, "Most of the changes in the practice of medicine have resulted from private coverage, and Medicare has been behind," said Gottleib, who early in his career completed a residency in internal medicine at the Mount Sinai Medical Center in New York. He added that Medicare has been "slow to embrace changes to the practice of medicine."
Referring to CAR-T cancer treatments, a gene therapy approach that has been FDA approved for about two years, he said, "Medicare hasn't figured out how to pay on the delivery of this medicine."
"When hospitals deliver this they're losing money on it," he claimed, saying they turn to clinical trials where the hospital will be reimbursed for the medication.
Meanwhile, Sen. Elizabeth Warren, also a Democratic presidential candidate, called on Gottlieb to resign from Pfizer's board.
"This kind of revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful about whether high-level Trump administration officials are working for them, or for their future corporate employers," Warren said in a letter on July 1, to Gottlieb.
— CNBC's Angelica Lavito contributed to this report.